STOCKHOLM, Sweden, Aug. 6, 2003 (PRIMEZONE) -- Pharmadule, a division of Pharmadule Emtunga AB, has been awarded a contract for a complete aseptic filling facility to Baxter Healthcare Corporation in the USA. The contract is valued to approx. USD 40 million with an option of additional USD 25 million. The facility will be designed in Stockholm and Gothenburg offices and manufactured at the production sites in Gothenburg and Emtunga. Hand over to Baxter will take place in January 2005.
For more information, please contact:
Tomas Wangberg, CEO
Tel: + 46 -512 324 44 Mobile:+ 46 -705 942 444 E-Mail: tomas.wangberg@pharmadule.com
About Pharmadule Emtunga AB
Pharmadule Emtunga AB is the world-leading supplier of high-tech modular facilities. Its activities encompass three different market segments that all share the modular technology, engineering and production resources. As of today division Pharmadule has supplied more than 40 plants worldwide to multinational companies such as Eli Lilly, Merck, Aventis, Pharmacia and AstraZeneca. Division Emtunga has delivered more than 100 projects to the oil and gas industry and division, FlexEnclosure several thousand base stations for the mobile telecom networks worldwide. The company has manufacturing plants in Sweden and sales offices located in Seattle, Houston, New Jersey -- USA and Stavanger -- Norway.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/08/06/20030806BIT00280/wkr0001.doc
http://www.waymaker.net/bitonline/2003/08/06/20030806BIT00280/wkr0002.pdf